Literature DB >> 25392003

Xenx (Xenolith): preliminary considerations of a new "all-in-one" ureteral guidewire and anti-repulsion device.

Emanuele Montanari1, Fabrizio Longo, Nicola Macchione, Olivier Traxer.   

Abstract

A new anti-retropulsion device for the endoscopic treatment of ureteral stones was evaluated for safety and potential efficacy. The Xenx™ (Rocamed, Monaco-Montecarlo) is an anti-retropulsion device that operates as a normal hydrophilic guidewire when "closed" and as a nitinol ureteral mesh when "open". We performed semirigid ureterorenoscopy and Ho:YAG Laser lithotripsy in 15 patients, with a single ureteral stone. For each procedure, the papilla was negotiated with the Xenx™, the radiopaque markers were positioned over the stone via direct visualization and the device was opened under fluoroscopic control. The ureteroscope was then retracted and reinserted beside the Xenx™. At the end of the procedure, the Xenx™ was closed, and a ureteral catheter was coaxially placed and left for 24-48 h post-operation. We evaluated device positioning success with respect to pushability, ease of deployment, full expansion and fitting with the ureteral walls, kink resistance and stone retention capabilities during lithotripsy and device retrieval. Operative time, post-operative complications (Clavien-Dindo scale), ultrasound kidney stone-free rate and the hydronephrosis grade, were also recorded. At 4 weeks post-operation, the stone-free rate was assessed via non-contrast computed tomography with 1-mm slices. All procedures were successfully accomplished without complications according to the Clavien-Dindo scale. In all the cases, Xenx™ was inserted successfully past the stone and opened over it. In 4/15 cases (27%) some difficulties in pushability and kink resistance were recorded. In no case stone fragment basketing was performed. The median operative time was 24 min. At hospital discharge, 14/15 patients (93%) were kidney stone-free. At 4 weeks, the NCCT stone-free rate was 100%. This study demonstrated that the Xenx™ is safe and effective in terms of the stone-free rate, complications and operating time. Moreover, use of the Xenx™ allows the use of a basket or guide wire to be avoided.

Entities:  

Mesh:

Year:  2014        PMID: 25392003     DOI: 10.1007/s00240-014-0740-6

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  17 in total

1.  Stone retropulsion during holmium:YAG lithotripsy.

Authors:  Ho Lee; R Tres Ryan; Joel M H Teichman; Jeehyun Kim; Bernard Choi; Navanit V Arakeri; A J Welch
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  In vitro evaluation of ureteral perforation forces.

Authors:  Renato N Pedro; Kari Hendlin; Derek Weiland; Anup Ramani; Tobias S Köhler; J Kyle Anderson; Manoj Monga
Journal:  Urology       Date:  2007-09       Impact factor: 2.649

3.  Systematic evaluation of ureteral occlusion devices: insertion, deployment, stone migration, and extraction.

Authors:  Mahfuza Ahmed; Renato N Pedro; Sam Kieley; Joseph W Akornor; William K Durfee; Manoj Monga
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

4.  Efficacy and safety of the Accordion stone-trapping device: in vitro results from an artificial ureterolithotripsy model.

Authors:  Peter Jochen Olbert; Christian Keil; Jost Weber; Andres J Schrader; Axel Hegele; Rainer Hofmann
Journal:  Urol Res       Date:  2009-11-27

5.  Avulsion of the ureter caused by stone basket manipulation.

Authors:  M Abdelsayed; E Onal; S H Wax
Journal:  J Urol       Date:  1977-11       Impact factor: 7.450

6.  A new alternative treatment for entrapped stone basket in the distal ureter.

Authors:  A C Durano; J J Hanosh
Journal:  J Urol       Date:  1988-01       Impact factor: 7.450

7.  Cost-effectiveness of anti-retropulsion devices for ureteroscopic lithotripsy.

Authors:  Michal Ursiny; Brian H Eisner
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

8.  Effect of holmium:YAG laser pulse width on lithotripsy retropulsion in vitro.

Authors:  David S Finley; Jasen Petersen; Corollos Abdelshehid; Michael Ahlering; David Chou; James Borin; Louis Eichel; Elspeth McDougall; Ralph V Clayman
Journal:  J Endourol       Date:  2005-10       Impact factor: 2.942

9.  The stone cone: a new generation of basketry.

Authors:  S P Dretler
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

10.  Ureteroscopic management of lower ureteric calculi: a 15-year single-centre experience.

Authors:  Osama M Elashry; Abdelnaser K Elgamasy; Magdy A Sabaa; Mohamed Abo-Elenien; Mohamed Adel Omar; Hassan H Eltatawy; Shawky A El-Abd
Journal:  BJU Int       Date:  2008-05-15       Impact factor: 5.588

View more
  1 in total

1.  Use of XenX™, the latest ureteric occlusion device with guide wire utility: results from a prospective multicentric comparative study.

Authors:  Francesco Sanguedolce; Emanuele Montanari; Mario Alvarez-Maestro; Nicola Macchione; Stephan Hruby; Athanasios Papatsoris; Panagiotis Kallidonis; Luca Villa; Patrick Honeck; Olivier Traxer; Francesco Greco
Journal:  World J Urol       Date:  2016-03-18       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.